CELLARIUM

THE KOREA REGENERATIVE MEDICINE GUIDE

GuidesClinics & HospitalsDoctorsPlan Your VisitSearchCompare Clinics
← Back to The Treatment Library

Evidence

Sample size and uncertainty

Small studies can reveal useful signals while leaving important questions unanswered.

“Use this guide to frame clear, indication-specific questions for your specialist consultation.”

PATIENT EVIDENCE & CONSULTATION GUIDE

Category: Evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

Why the number of participants matters

A study with few participants may miss uncommon harms and produce an unstable estimate of benefit. One or two outcomes can change a percentage substantially. Small studies are often appropriate early in development, but their conclusions should match their size and purpose. A positive result in a handful of people is not equivalent to a reliable estimate for a broad patient population.

Look beyond the average

Reports may include confidence intervals to show uncertainty around an estimate. A wide interval means the data remain compatible with a broad range of effects. Patients do not need advanced statistics to ask whether the result is precise enough to guide a decision. The presence of a favorable average does not eliminate uncertainty about the true effect.

Safety requires enough observation

If no serious complication occurs in a small group, that does not prove the risk is zero. Rare or delayed events may not appear until more people are treated or followed longer. Ask how many people received the exact product and how much follow-up is available. Safety claims should be proportional to the amount of observation.

How to use early evidence

Early data can justify further study and help shape questions for a specialist. They should not be dismissed simply because the study is small, but neither should they be treated as final proof. Ask what confirmatory studies are planned or completed and whether the broader evidence points in the same direction.

Continue exploring

  • Preclinical research: before a treatment reaches people
  • Blinding and placebo effects
  • Clinical endpoints: what counts as improvement
  • Prepare your consultation checklist

Sources & further reading

  • National Cancer Institute — How Clinical Trials Work
  • ISSCR — Guide to Stem Cell Treatments

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.

CONTINUE YOUR PREPARATION

Prepare for your clinical conversation.

Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.

Consultation ChecklistExplore Clinics & HospitalsAll 147 Guides

CELLARIUM

Knowledge before possibility.

Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.

EDITORIAL DIRECTORY

The Treatment Library (147 Guides)Clinics & Hospitals in SeoulMeet the DoctorsSide-by-Side Clinic ComparisonConsultation Checklist & PlanningEditorial ApproachPrivacy & Site Information

© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.